In a convention last week, Teva’s CFO said the comp. is looking for big branded acquisitions in the range of $2B-$8B, in cancer, neurology and immunology arenas.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.